Board of Directors

BioTelemetry, Inc. (Nasdaq: BEAT)

Kirk Gorman

Chairman, BioTelemetry, Inc., and Senior Vice President and Chief Financial Officer, Jefferson Health Systems

Mr. Gorman retired in 2016 after having served as the Executive Vice President, Chief Financial Officer of Thomas Jefferson University, an academic medical center in Philadelphia. Mr. Gorman served as Executive Vice President and Chief Financial Officer of Jefferson Health System, a multi-hospital system in Philadelphia, Pennsylvania from September 2003 to June of 2014. Mr. Gorman has also been a member of the board of directors and Audit Committee of IASIS Healthcare LLC since February 2004. From April 1987 to March 2003, Mr. Gorman served as the Senior Vice President, Chief Financial Officer of Universal Health Services, Inc., a hospital management company and President, Chief Financial Officer and a member of the Board of Trustees of Universal Health Realty Income Trust, a real estate investment trust specializing in healthcare and human service related facilities. Mr. Gorman previously served on the board of directors of Health Management Associates, Care Investment Trust and VIASYS Healthcare, Inc.

Joseph H. Capper

President and Chief Executive Officer, BioTelemetry, Inc.

Joe Capper was appointed President and Chief Executive Officer of CardioNet in June 2010 and now serves in that same capacity for BioTelemetry. Prior to CardioNet, Joe served as President, Chief Executive Officer and member of the Board of Directors of Home Diagnostics, Inc., a leading developer, manufacturer and marketer of diabetes management products. Joe joined Home Diagnostics in 2009 and positioned the Company for a strategic merger in a transaction that created substantial value to its stakeholders. Home Diagnostics was listed on the NASDAQ stock market until its strategic merger.
Prior to Home Diagnostics, Joe was President and Chief Executive Officer of CCS Medical Inc., a private company that is a leading provider of medical supplies in diabetes, wound care, respiratory and other therapeutic categories. During Joe’s tenure as Chief Executive Officer, he built the Company into one of the largest providers of diabetes and respiratory testing supplies for Medicare beneficiaries and the private insured. During this time, the Company’s revenue grew from $60 million to over $500 million through organic growth and acquisitions.
Earlier in his career, Joe spent nine years with Bayer Corporation, ultimately becoming National Sales Director of the Diabetic Products Division where he led a 180-person sales organization with responsibility for over $350 million in revenue. Joe also has a distinguished service record having served in the U.S. Navy as a combat aviator and subsequently as a Congressional Liaison. Joe received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University.

Anthony J. Conti

Board Member

Mr. Conti joined the CardioNet Board of Directors in May 2012, serving as the Chairman of its Audit Committee and now serves in that same capacity for BioTelemetry. He joined Coopers and Lybrand in 1973 and served a wide range of technology, utility and health services clients. He held a number of leadership roles with Coopers and Lybrand, and later with PricewaterhouseCoopers, after its merger with Price Waterhouse in 1998. Mr. Conti serves as the Chairman of the Audit Committee for Ametek, Inc., an electronic instrument and electromechanical device company. He previously served as Chairman of the Board of the World Affairs Council of Philadelphia until December of 2011, and now serves as Chairman Emeritus. He also served as a Member of the Board and Executive Committee of the United Way of Southeastern Pennsylvania. Mr. Conti holds a Bachelors of Arts degree in Economics from St. Joseph’s University and a Masters of Business Administration from Temple University.

Joseph A. Frick

Vice Chairman and Managing Partner of Diversified Search

Mr. Frick joined the BioTelemetry Board of Directors in October, 2013, serving as a member of its Compensation Committee. He is currently Vice Chairman and Managing Partner of Diversified Search, one of the top ten executive search firms in the United States. Prior to joining Diversified, Mr. Frick served as President and CEO of Independence Blue Cross, and is currently a Vice Chair of the Independence Blue Cross Board of Directors. Prior to becoming CEO of Independence Blue Cross in 2005, Mr. Frick served various roles including Senior Vice President of Human Resources. Before joining Independence Blue Cross, Mr. Frick was Vice President of Human Resources at Philadelphia Newspapers, Inc. Earlier in his career, Mr. Frick worked for Westinghouse Electric Corporation, holding a variety of managerial positions in operations administration and human resources. Mr. Frick also serves as a Board member for LaSalle University, the Colon Cancer Alliance, Triple-S Management Corporation and the CEO Roundtable on Cancer. Mr. Frick also serves as a member of the PNC Bank Regional Advisory Board. He holds a Bachelors of Arts degree in Liberal Arts from the University of Notre Dame and a Masters of Business Administration in Management from Loyola College.

Colin Hill

Board Member

Mr. Hill co-founded GNS Healthcare in 2000 and has served as Chairman and Chief Executive Officer since its inception.  He serves as Chairman of Via Science, a leading machine learning and simulation company focused on the Internet of Things, business intelligence, and security.  He was appointed in 2015 by Massachusetts Governor Charlie Baker to the Board of Directors of the Center for Health Information and Analysis. Mr. Hill is also a founding Board member of Transforming Medicine: The Elizabeth Kauffmann Institute, a non-profit foundation dedicated to the advancement of personalized medicine.  Mr. Hill also was a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease, which was acquired by Baxter International Inc. in 2014.  Mr. Hill was the founding chairman of O’Reilly Media’s Strata Rx in 2012, the first healthcare big data conference, and was the founding chairman of big data quantitative trading film Fina Technologies, for which he served from 2008 to 2011. In 2004, Mr. Hill was named to MIT Technology Review’s TR100 list of top 100 innovators in the world under age 35. Mr. Hill graduated from Virginia Tech with a degree in physics and earned Masters degrees in physics from both McGill University and Cornell University.

Robert J. Rubin, M.D.

Clinical Professor of Medicine, Georgetown University

Dr. Rubin has been a member of our board of directors since July 2007. He has been a clinical professor of medicine at Georgetown University since 1995. From 1987 to 2001, he was president of the Lewin Group (purchased by Quintiles Transnational Corp. in 1996), a national health policy and management consulting firm. From 1994 to 1996, Dr. Rubin served as Medical Director of ValueRx, a pharmaceutical benefits company. From 1992 to 1996, Dr. Rubin served as President of Lewin-VHI, a health care consulting company. From 1987 to 1992, he served as President of Lewin-ICF, a health care consulting company. From 1984 to 1987, Dr. Rubin served as a principal for ICF, Inc., a health care consulting company. From 1981 to 1984, Dr. Rubin served as the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services and as an Assistant Surgeon General in the United States Public Health Service. Dr. Rubin is a board certified nephrologist and internist. Dr. Rubin received an undergraduate degree in political science from Williams College and an M.D. from Cornell University.

BioTelemetry, Inc.